Search bioRxiv⌕ Search

Biology subjects

Ao, D.

Publications and source records attributed to Ao, D..

6 recordsLinked to original sources

The Neuromusculoskeletal Modeling Pipeline: MATLAB-based Model Personalization and Treatment Optimization Functionality for OpenSim

Neuromusculoskeletal injuries including osteoarthritis, stroke, spinal cord injury, and traumatic brain injury affect roughly 19% of the U.S. adult population. Standardized interventions have produced suboptimal functional outcomes due to the unique treatment needs of each patient. Strides have been made to utilize computational models to develop personalized treatments, but researchers and clinicians have yet to cross the "valley of death" between fundamental research and clinical usefulness. This article introduces the Neuromusculoskeletal Modeling (NMSM) Pipeline, two MATLAB-based toolsets that add Model Personalization and Treatment Optimization functionality to OpenSim. The two toolsets facilitate computational design of individualized treatments for neuromusculoskeletal impairments through the use of personalized neuromusculoskeletal models and predictive simulation. The Model Personalization toolset contains four tools for personalizing 1) joint structure models, 2) muscle-tendon models, 3) neural control models, and 4) foot-ground contact models. The Treatment Optimization toolset contains three tools for predicting and optimizing a patients functional outcome for different treatment options using a patients personalized neuromusculoskeletal model with direct collocation optimal control methods. Support for user-defined cost functions and model modification functions facilitate simulation of a vast number of possible treatments. An NMSM Pipeline use case is presented for an individual post-stroke with impaired walking function, where the goal was to predict how the subjects neural control could be changed to improve walking speed without increasing metabolic cost. First the Model Personalization toolset was used to develop a personalized neuromusculoskeletal model of the subject starting from a generic OpenSim full- body model and experimental walking data (video motion capture, ground reaction, and electromyography) collected from the subject at his self-selected speed. Next the Treatment Optimization toolset was used with the personalized model to predict how the subject could recruit existing muscle synergies more effectively to reduce muscle activation disparities between the paretic and non-paretic legs. The software predicted that the subject could increase his walking speed by 60% without increasing his metabolic cost per unit time by modifying existing muscle synergy recruitment. This hypothetical treatment demonstrates how NMSM Pipeline tools could allow researchers working collaboratively with clinicians to develop personalized neuromusculoskeletal models of individual patients and to perform predictive simulations for the purpose of designing personalized treatments that maximize a patients post-treatment functional outcome.

bioengineering↗

Comparison of Synergy Extrapolation and Static Optimization for Estimating Multiple Unmeasured Muscle Activations during Walking

BackgroundCalibrated electromyography (EMG)-driven musculoskeletal models can provide great insight into internal quantities (e.g., muscle forces) that are difficult or impossible to measure experimentally. However, the need for EMG data from all involved muscles presents a significant barrier to the widespread application of EMG-driven modeling methods. Synergy extrapolation (SynX) is a computational method that can estimate a single missing EMG signal with reasonable accuracy during the EMG-driven model calibration process, yet its performance in estimating a larger number of missing EMG signals remains unclear. MethodsThis study assessed the accuracy with which SynX can use eight measured EMG signals to estimate muscle activations and forces associated with eight missing EMG signals in the same leg during walking while simultaneously performing EMG-driven model calibration. Experimental gait data collected from two individuals post-stroke, including 16 channels of EMG data per leg, were used to calibrate an EMG-driven musculoskeletal model, providing "gold standard" muscle activations and forces for evaluation purposes. SynX was then used to predict the muscle activations and forces associated with the eight missing EMG signals while simultaneously calibrating EMG-driven model parameter values. Due to its widespread use, static optimization (SO) was also utilized to estimate the same muscle activations and forces. Estimation accuracy for SynX and SO was evaluated using root mean square errors (RMSE) to quantify amplitude errors and correlation coefficient r values to quantify shape similarity, each calculated with respect to "gold standard" muscle activations and forces. ResultsOn average, SynX produced significantly more accurate amplitude and shape estimates for unmeasured muscle activations (RMSE 0.08 vs. 0.15, r value 0.55 vs. 0.12) and forces (RMSE 101.3 N vs. 174.4 N, r value 0.53 vs. 0.07) compared to SO. SynX yielded calibrated Hill-type muscle-tendon model parameter values for all muscles and activation dynamics model parameter values for measured muscles that were similar to "gold standard" calibrated model parameter values. ConclusionsThese findings suggest that SynX could make it possible to calibrate EMG-driven musculoskeletal models for all important lower-extremity muscles with as few as eight carefully chosen EMG signals and eventually contribute to the design of personalized rehabilitation and surgical interventions for mobility impairments.

biophysics↗

Changes in Walking Function and Neural Control following Pelvic Cancer Surgery with Reconstruction

Surgical planning and custom prosthesis design for pelvic cancer patients is challenging due to the unique clinical characteristics of each patient and the significant amount of pelvic bone and hip musculature often removed. Limb-sparing internal hemipelvectomy surgery with custom prosthesis reconstruction has become a viable option for this patient population. However, little is known about how post-surgery walking function and neural control change from pre-surgery conditions. This case study combined comprehensive human movement data collection with personalized neuromusculoskeletal computer modeling to provide a thorough assessment of pre-to post-surgery changes in walking function and neural control for a single pelvic sarcoma patient who received internal hemipelvectomy surgery with custom prosthesis reconstruction. Extensive walking data (video motion capture, ground reaction, and EMG) were collected from the patient before surgery and after plateau in recovery after surgery. Pre- and post-surgery personalized neuromusculoskeletal computer models of the patient were then constructed using the patients pre- and post-surgery walking data. These models were used to calculate the patients pre- and post-surgery joint motions, joint moments, and muscle synergies. The calculated muscle synergies were described by time-invariant synergy vectors and time-varying synergy activations, were consistent with the patients experimental EMG data, and produced the patients experimental joint moments found via inverse dynamics. The patients post-surgery walking function was marked by a slower self-selected walking speed coupled with several compensatory mechanisms necessitated by lost or impaired hip muscle function, while the patients post-surgery neural control demonstrated a dramatic change in coordination strategy (as evidenced by modified synergy vectors) with little change in recruitment timing (as evidenced by conserved synergy activations). Furthermore, the patients post-surgery muscle activations were fitted accurately using the patients pre-surgery synergy activations but poorly using the patients pre-surgery synergy vectors. These results provide valuable information about which aspects of post-surgery walking function could potentially be improved through modifications to surgical decisions, custom prosthesis design, or rehabilitation protocol, as well as how computational simulations could be formulated to predict post-surgery walking function reliably given a patients pre-surgery walking data and the planned surgical decisions and custom prosthesis design.

bioengineering↗

African swine fever virus structural protein p17 inhibits cGAS-STING signaling pathway through interacting with STING

African swine fever (ASF) is highly contagious, causes high mortality in domestic and feral swine, and has a significant economic impact on the global swine industry due to the lack of a vaccine or an effective treatment. African swine fever virus (ASFV) encodes more than 150 polypeptides, which may have intricate and delicate interactions with the host for the benefit of the virus to evade the hosts defenses. However, currently, there is still a lack of information regarding the roles of the viral proteins in host cells. Here, our data demonstrated that the p17, encoded by D117L gene could suppress porcine cGAS-STING signaling pathway, exhibiting the inhibitions of TBK1 and IRF3 phosphorylations, downstream promoter activities, cellular mRNA transcriptions and ISG56 induction, and antiviral responses. Further, we found that p17 was located in endoplasmic reticulum (ER) and Golgi apparatus, and interacted with STING, perturbing it in the recruitment of TBK1 and IKK{varepsilon}. Additionally, it appeared that the transmembrane domain (amino acids 39-59) of p17 could be required for interacting with STING and inhibiting cGAS-STING pathway. Taken together, p17 could inhibit the cGAS-STING pathway through its interaction with STING and interference with STING in the recruitment of TBK1 and IKK{varepsilon}. ImportanceAfrican swine fever (ASF) is a highly contagious disease in domestic and feral swine, posing significant economic impacts on the global swine industry, and the pathogen ASFV is a large icosahedral DNA virus. The innate immune cGAS-STING DNA sensing pathway plays a critical role in sensing invading ASFV and triggering antiviral responses. However, there is still a lack of information regarding the molecular mechanisms of ASFV evasion of the cGAS-STING pathway. We have analyzed the effects of whole genomic open reading frames (ORFs) of ASFV China 2018/1 on the activation of cGAS-STING pathway, and found that p17 was able to inhibit cGAS-STING mediated type I IFN production by targeting STING, altering its capacity to recruit both TBK1 and IKK{varepsilon}. Findings presented here will expand our knowledge on the molecular mechanisms by which ASFV counteracts the antiviral innate immunity and provide deep insights into ASF pathogenesis.

immunology↗

Evaluation of Synergy Extrapolation for Predicting Unmeasured Muscle Excitations from Measured Muscle Synergies

Electromyography (EMG)-driven musculoskeletal modeling relies on high-quality measurements of muscle electrical activity to estimate muscle forces. However, a critical challenge for practical deployment of this approach is missing EMG data from muscles that contribute substantially to joint moments. This situation may arise due to either the inability to measure deep muscles with surface electrodes or the lack of a sufficient number of EMG electrodes. Muscle synergy analysis is a dimensionality-reduction approach to decompose a large number of muscle excitations into a small number of time-varying synergy excitations along with time-invariant synergy weights that define the contribution of each corresponding synergy excitation to a specific muscle excitation. This study evaluates how accurately missing muscle excitations can be predicted using synergy excitations extracted from muscles with available EMGs (henceforth called "synergy extrapolation"). The results were reported on a gait dataset collected from a stroke survivor walking on an instrumented treadmill at self-selected and fastest-comfortable speeds. The evaluation process started with full calibration of a lower-body EMG-driven model using 16-channel EMGs (including surface and indwelling) in each leg. One indwelling EMG (either iliopsoas or adductor longus) was then treated as unmeasured at a time. The synergy weights associated with the unmeasured muscle were predicted through solving a nonlinear optimization problem where the errors between inverse dynamics and EMG-driven joint moments were minimized. We also quantitatively evaluated how synergy analysis algorithms (principal component analysis (PCA) and non-negative matrix factorization (NMF)), EMG normalization methods, and number of synergies affect the accuracy of the predicted unmeasured muscle excitation. Synergy extrapolation performance was most influenced by the choice of synergy analysis algorithm and number of synergies. PCA with 5 or 6 synergies consistently predicted unmeasured muscle excitations most accurately and with greatest robustness to choice of EMG normalization method. Furthermore, the associated joint moment matching accuracy was comparable to that produced by the full EMG-driven calibration. The synergy extrapolation method described in this study may facilitate the assessment of human neuromuscular control and biomechanics in response to surgical or rehabilitation treatment when important EMG signals are missing.

bioengineering↗

How Well Do Commonly Used Co-Contraction Indices Approximate Lower Limb Joint Stiffness Trends during Gait?

Muscle co-contraction generates joint stiffness to improve stability and accuracy during limb movement but at the expense of higher energetic cost. The quantification of joint stiffness generated from muscle co-contraction is difficult through both experimental and computational means for its benefit and cost to be assessed. Quantification of muscle co-contraction may offer an alternative path for estimating joint stiffness. By choosing the commonly used Co-Contraction Indices (CCIs) to represent muscle co-contraction, this study investigated the feasibility of using CCI to approximate lower limb joint stiffness trends during gait. A calibrated EMG-driven musculoskeletal model of a hemiparetic individual post-stroke from a previous study was used to generate the quantities required for CCI calculation and model-based estimation of joint stiffness. A total of 14 classes of CCIs for various combinations of antagonistic muscle pairs were calculated based on two common CCI formulations, each with 7 types of quantities that included variations of electromyography (EMG) signals and joint moments from the muscles. Correlations between CCIs and model-based estimates of sagittal plane stiffness of the lower extremity joints (hip, knee, ankle) were computed. Although moderate to strong correlation was observed between some CCI formulations and the corresponding joint stiffness, these associations were highly dependent on the methodological choices made for CCI computation. The overall findings of this study were the following: (1) the formulation proposed by Rudolph et al. (2000), CCI1, was more correlated with joint stiffness than that of Falconer and Winter (1985); (2) Moment-based CCI1 from individual antagonistic muscle pairs was more correlated than EMG-based CCI1; (3) EMG signals with calibrated electromechanical delay and joint moment generated by individual muscle without normalization to a reference value were the most correlated for EMG-based CCI1 and moment-based CCI1, respectively. The combination of antagonistic muscle pairs for most correlated within each CCI class was also identified. By using CCI to approximate joint stiffness trends, this study may open an alternative path to studying joint stiffness.

bioengineering↗